Annual report
5199.TEDINET S100R73J
Period2022-04-01 → 2023-03-31
Filed2023-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 144
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥8.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥6.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥761m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥529m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥730m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥486m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥227m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥34m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥527m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥722m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥63m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥517m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥143m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥170m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥27m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥398m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥517m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | −¥143m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥11.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥11.8bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥12.4bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥12.7bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥13.6bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.9bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥8.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.3bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥3.1bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.2bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.9bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.6bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥772m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥706m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥440m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥292m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥76m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥152m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥111m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥515m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.0bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥676m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥803m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥450m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥316m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥407.89 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-112.56 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥134.03 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-20.94 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥313.33 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,820.6 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,442.65 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,604.82 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,455.88 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,551.96 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 31.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.2% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.6% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.6% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.9% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 15.5% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.9% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 276 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 287 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 285 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 292 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 297 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥8.0bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥8.1bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥6.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.1bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥745m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥535m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥714m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥496m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥213m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥29m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥507m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥705m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥89m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥504m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥167m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥160m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥30m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥382m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥11.4bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥11.7bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥12.4bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥12.6bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥13.5bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.9bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥8.7bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.5bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.0bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.3bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥3.1bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.2bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥397.23 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-131.92 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥125.82 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-23.84 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥301.24 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥50 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,760.74 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,388.09 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,575.31 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,464.1 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,559.68 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 30.8% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.8% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.0% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 15.4% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.0% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.3% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,286,199 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,286,199 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,286,199 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,286,199 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,286,199 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 272 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 281 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 279 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 286 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 291 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 60
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥2m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥24m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥2.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥444m |
| Medical Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥10m |
| Medical Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥119m |
| Medical Equipmentreportable segment | employees | at 2023-03-31 | 114 pure |
| Medical Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥2.3bn |
| Medical Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥2.3bn |
| Medical Equipmentreportable segment | segment assets | at 2023-03-31 | ¥3.6bn |
| Medical Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥104m |
| Precision Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥67m |
| Precision Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥188m |
| Precision Equipmentreportable segment | employees | at 2023-03-31 | 131 pure |
| Precision Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥5.1bn |
| Precision Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥5.1bn |
| Precision Equipmentreportable segment | segment assets | at 2023-03-31 | ¥4.3bn |
| Precision Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.2bn |
| SP Divisionreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥55,000 |
| SP Divisionreportable segment | employees | at 2023-03-31 | 2 pure |
| SP Divisionreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥414m |
| SP Divisionreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥414m |
| SP Divisionreportable segment | segment assets | at 2023-03-31 | ¥238m |
| SP Divisionreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥16m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥77m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥328m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥8.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥8.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥8.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥1.2bn |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥2m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥27m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥2.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥454m |
| Medical Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥24m |
| Medical Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥206m |
| Medical Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| Medical Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| Medical Equipmentreportable segment | segment assets | at 2022-03-31 | ¥3.6bn |
| Medical Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥283m |
| Precision Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥117m |
| Precision Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥214m |
| Precision Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥5.3bn |
| Precision Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥5.3bn |
| Precision Equipmentreportable segment | segment assets | at 2022-03-31 | ¥4.7bn |
| Precision Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| SP Divisionreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥91,000 |
| SP Divisionreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥330m |
| SP Divisionreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥330m |
| SP Divisionreportable segment | segment assets | at 2022-03-31 | ¥191m |
| SP Divisionreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥8m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥141m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥443m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥8.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥8.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥8.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥983m |
| Medical Equipmentreportable segment | employees | at 2023-03-31 | 113 pure |
| Precision Equipmentreportable segment | employees | at 2023-03-31 | 128 pure |
| SP Divisionreportable segment | employees | at 2023-03-31 | 2 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,537
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes receivable trade | CurrentYearInstant | 52389000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 1700382000 | JPY |
| Accounts receivable trade | CurrentYearInstant | 1575799000 | JPY |
| Advances received | Prior1YearInstant | 11054000 | JPY |
| Advances received | CurrentYearInstant | 5982000 | JPY |
| Write downs of inventories | Prior1YearDuration | 317018000 | JPY |
| Write downs of inventories | CurrentYearDuration | -234888000 | JPY |
| Salaries and bonuses sga | Prior1YearDuration | 462980000 | JPY |
| Salaries and bonuses sga | CurrentYearDuration | 437108000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 17366000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 15465000 | JPY |
| Provision for bonuses sga | Prior1YearDuration | 58542000 | JPY |
| Provision for bonuses sga | CurrentYearDuration | 57299000 | JPY |
| Welfare expenses sga | Prior1YearDuration | 98435000 | JPY |
| Welfare expenses sga | CurrentYearDuration | 97047000 | JPY |
| Freightage expenses sga | Prior1YearDuration | 110883000 | JPY |
| Freightage expenses sga | CurrentYearDuration | 133230000 | JPY |
| Advertising expenses sga | Prior1YearDuration | 1208000 | JPY |
| Advertising expenses sga | CurrentYearDuration | 532000 | JPY |
| Promotion expenses sga | Prior1YearDuration | 41143000 | JPY |
| Promotion expenses sga | CurrentYearDuration | 34120000 | JPY |
| Depreciation sga | Prior1YearDuration | 32233000 | JPY |
| Depreciation sga | CurrentYearDuration | 28419000 | JPY |
| Commission fee sga | Prior1YearDuration | 100694000 | JPY |
| Commission fee sga | CurrentYearDuration | 116724000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | Prior1YearDuration | 206313000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | CurrentYearDuration | 195837000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01109-000MedicalEquipmentReportableSegmentsMember | 2301092000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01109-000PrecisionEquipmentReportableSegmentsMember | 5316728000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01109-000SPDivisionReportableSegmentMember | 330412000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01109-000FoodContainerMember | 199103000 | JPY |
| Revenues from external customers | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 8147337000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 8147337000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01109-000MedicalEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01109-000PrecisionEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01109-000SPDivisionReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01109-000FoodContainerMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01109-000MedicalEquipmentReportableSegmentsMember | 2301092000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01109-000PrecisionEquipmentReportableSegmentsMember | 5316728000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01109-000SPDivisionReportableSegmentMember | 330412000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01109-000FoodContainerMember | 199103000 | JPY |
| Net sales | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 8147337000 | JPY |
| Net sales | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YearDuration | 8147337000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E01109-000MedicalEquipmentReportableSegmentsMember | -282930000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E01109-000PrecisionEquipmentReportableSegmentsMember | 1259218000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |